Stem Cell Replenishment Act of 2004
Official title: To authorize the use of Federal funds for research on human embryonic stem cells irrespective of the date on which such stem cells were derived, and for other purposes.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
Stem Cell Replenishment Act of 2004 - Allows Federal funds to be used for research on human embryonic stem cells irrespective of the date on which the derivation process for such stem cells was initiated or completed. (Current law requires the derivation process to have begun by August 9, 2001.) Requires the Director of the National Institutes of Health to revise human embryonic stem cell research guidelines to the extent necessary to ensure the availability of not less than 60 stem cell lines that are scientifically fit for distribution or research.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 3960: Stem Cell Replenishment Act of 2004. 108th Congress. Open America. https://openamerica.io/bill/108-HR-3960/
"H.R. 3960: Stem Cell Replenishment Act of 2004." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-HR-3960/.
H.R. 3960, 108th Cong. (2026), https://openamerica.io/bill/108-HR-3960/.
[H.R. 3960: Stem Cell Replenishment Act of 2004](https://openamerica.io/bill/108-HR-3960/)